Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Want to see HK:0455 full AI Analyst Report?
Total Valuation
Tianda Pharmaceuticals Ltd. has a market cap or net worth of HK$195.65M. The enterprise value is HK$263.50M.
Market CapHK$195.65M
Enterprise ValueHK$263.50M
Share Statistics
Tianda Pharmaceuticals Ltd. has 2,150,041,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,150,041,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tianda Pharmaceuticals Ltd.’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -9.07%.
Return on Equity (ROE)-0.15
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-9.07%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee460.69K
Profits Per Employee-99.85K
Employee Count701
Asset Turnover0.43
Inventory Turnover4.24
Valuation Ratios
The current PE Ratio of Tianda Pharmaceuticals Ltd. is ―. Tianda Pharmaceuticals Ltd.’s PEG ratio is -0.28.
PE Ratio―
PS Ratio0.86
PB Ratio0.61
Price to Fair Value0.61
Price to FCF99.20
Price to Operating Cash Flow19.68
PEG Ratio-0.28
Income Statement
In the last 12 months, Tianda Pharmaceuticals Ltd. had revenue of 322.94M and earned -70.00M in profits. Earnings per share was -0.03.
Revenue322.94M
Gross Profit133.31M
Operating Income-54.09M
Pretax Income-69.33M
Net Income-70.00M
EBITDA-24.41M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -10.29M and capital expenditures -3.90M, giving a free cash flow of -14.19M billion.
Operating Cash Flow-10.29M
Free Cash Flow-14.19M
Free Cash Flow per Share>-0.01
Dividends & Yields
Tianda Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change-35.00%
50-Day Moving Average0.10
200-Day Moving Average0.13
Relative Strength Index (RSI)35.15
Average Volume (3m)84.94K
Important Dates
Tianda Pharmaceuticals Ltd. upcoming earnings date is Sep 2, 2026, TBA (Not Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
Tianda Pharmaceuticals Ltd. as a current ratio of 0.83, with Debt / Equity ratio of 29.05%
Current Ratio0.83
Quick Ratio0.64
Debt to Market Cap0.46
Net Debt to EBITDA-2.78
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Tianda Pharmaceuticals Ltd. has paid 926.00K in taxes.
Income Tax926.00K
Effective Tax Rate-0.01
Enterprise Valuation
Tianda Pharmaceuticals Ltd. EV to EBITDA ratio is -14.14, with an EV/FCF ratio of 123.46.
EV to Sales1.07
EV to EBITDA-14.14
EV to Free Cash Flow123.46
EV to Operating Cash Flow23.94
Balance Sheet
Tianda Pharmaceuticals Ltd. has HK$64.81M in cash and marketable securities with HK$132.66M in debt, giving a net cash position of -HK$67.85M billion.
Cash & Marketable SecuritiesHK$64.81M
Total DebtHK$132.66M
Net Cash-HK$67.85M
Net Cash Per Share-HK$0.03
Tangible Book Value Per ShareHK$0.14
Margins
Gross margin is 42.45%, with operating margin of -16.75%, and net profit margin of -21.67%.
Gross Margin42.45%
Operating Margin-16.75%
Pretax Margin-21.47%
Net Profit Margin-21.67%
EBITDA Margin-7.56%
EBIT Margin-16.75%
Analyst Forecast
The average price target for Tianda Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.12%
EPS Growth Forecast-13.99%